Stocks
Horizon Discovery OrdinaryHRZDF
HealthcareBiotechnology
A provider of gene editing and gene modulation technologies, offering tools and services for research and therapeutic development. Its platforms support applications in oncology, rare disease, and cell line engineering, making it a key supplier to biopharma and academic labs. Investors track the company for its exposure to the growing CRISPR and synthetic biology markets.
Congressional Interest in Horizon Discovery Ordinary (HRZDF)
1 member of Congress has disclosed 1 trade in Horizon Discovery Ordinary (HRZDF), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading HRZDF?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-05-11 | Donald Sternoff Beyer | sell | $1K-$15K |